Badullewa,ChamikaRodrigo, U. A. A2026-09-202026-09-202026-05-021012-8999https://dr.ichemc.ac.lk/handle/123456789/490Abstract No: 2025_443 Page No 99Human pancreatic α-amylase is an important therapeutic target for drug development to control postprandial blood glucose levels in Type 2 Diabetes Mellitus (T2DM).enAlpha-amylaseCurcuminMolecular DockingType 2 DiabetesEthnopharmacologIn silico comparative analysis of curcumin and acarbose as inhibitors of human pancreatic alpha-amylaseArticle